Alzheimer's disease progression
Disease1 paper1 finding
- In silico1
Associations
1Amyloid PET
upin humans1
1 study
Amyloid PET
upin humans1
Amyloid PET is associated with Alzheimer's disease progression in humans.
Humans
Divergent amyloid trajectories distinguish normal aging from Alzheimer's disease progression · bioRxiv : the preprint server for biology · 14 Sep 2026 · Preprint
Funding
National Institute on AgingUS$3.2m6 grants since 2023
National Institute on AgingUniversity of Missouri-ColumbiaUS$540.4k2026–2030
Data-driven Subtypes of Alzheimer's disease progression for targeted treatment
National Institute on AgingUniversity of Texas Hlth Sci Ctr HoustonUS$778.5k2024–2029
National Institute on AgingUniversity of Texas Hlth Science CenterUS$490.8k2024–2029
The Role of Viral Exposure and Age in Alzheimer's Disease Progression
National Institute on AgingTulane University of LouisianaUS$537.2k2023–2028
Investigating the Impact of Novel Senescent Microglia in Alzheimer's Disease Progression
National Institute on AgingUniversity of Texas Hlth Science CenterUS$165.8k2024–2027
National Institute on AgingUniversity of Michigan at Ann ArborUS$284.1k2026–2027
Latest
13Model forecasts Alzheimer's progression before diagnosis
In 15,727 participants, a model detected decline before diagnosis in 22.41% of people progressing from mild cognitive impairment to Alzheimer's…In 15,727 participants, a model detected decline before diagnosis in 22.41% of people progressing from mild cognitive impairment to Alzheimer's disease.
APOE disease risks and proteomic links vary by ancestry
A phenome-wide study of 367,757 All of Us participants linked APOE alleles to 27 phenotypes, finding ancestry-specific risks for dementia and fatty…A phenome-wide study of 367,757 All of Us participants linked APOE alleles to 27 phenotypes, finding ancestry-specific risks for dementia and fatty liver disease.